A research group led by Takumi Kagawa and Masashi Kato at Nagoya University Graduate School of Medicine has discovered that ...
Cognito Therapeutics today announced new data from its OVERTURE feasibility trial evaluating its Spectris neuromodulation ...
Pharmaceutical Technology on MSN5d
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patientsDespite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper hand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback